异基因造血干细胞移植后巨细胞病毒病的风险适应性抢先治疗：韩国单中心经验 - Suppr

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.

作者信息

Choi Su-Mi, Lee Dong-Gun, Choi Jung-Hyun, Yoo Jin-Hong, Kim Yoo-Jin, Park Sun Hee, Min Chang-Ki, Lee Seok, Kim Hee-Je, Kim Dong-Wook, Lee Jong-Wook, Min Woo-Sung, Shin Wan-Shik, Kim Chun-Choo

出版信息

Int J Hematol. 2006 Apr;83(3):277-8. doi: 10.1007/BF02985486.

DOI:10.1007/BF02985486

PMID:16720564

Abstract

摘要

相似文献

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.异基因造血干细胞移植后巨细胞病毒病的风险适应性抢先治疗：韩国单中心经验

Int J Hematol. 2006 Apr;83(3):277-8. doi: 10.1007/BF02985486.

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.异基因造血干细胞移植后巨细胞病毒疾病的风险适应性抢先治疗：韩国的单中心经验

Int J Hematol. 2005 Jan;81(1):69-74. doi: 10.1532/ijh97.a30402.

Immunological monitoring for guidance of preemptive antiviral therapy for active cytomegalovirus infection in allogeneic stem-cell transplant recipients: a pilot experience.免疫监测指导异基因造血干细胞移植受者活动性巨细胞病毒感染的抢先抗病毒治疗：一项初步经验

Transplantation. 2011 Aug 27;92(4):e17-20. doi: 10.1097/TP.0b013e318224f263.

No indication of increased infection rates using low-dose alemtuzumab instead of anti-thymocyte globulin as graft-versus-host disease prophylaxis before allogeneic stem cell transplantation.

Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12822. Epub 2017 Dec 27.

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation.

Int J Hematol. 2005 Jun;81(5):439-40. doi: 10.1532/ijh97.05036.

Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.异基因造血干细胞移植受者的巨细胞病毒感染管理：西班牙的一项全国性调查

J Clin Microbiol. 2015 Aug;53(8):2741-4. doi: 10.1128/JCM.01057-15. Epub 2015 Jun 10.

Risk factors for progression from cytomegalovirus viremia to cytomegalovirus disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后从巨细胞病毒血症进展为巨细胞病毒病的危险因素。

Biol Blood Marrow Transplant. 2012 Jun;18(6):881-6. doi: 10.1016/j.bbmt.2011.10.037. Epub 2011 Nov 4.

Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience.儿童异基因造血干细胞移植中的巨细胞病毒感染。单中心经验。

Pediatr Hematol Oncol. 2014 Nov;31(8):743-53. doi: 10.3109/08880018.2013.859188. Epub 2013 Dec 5.

Preemptive therapy for cytomegalovirus disease in allogeneic stem cell transplant recipients.异基因干细胞移植受者巨细胞病毒病的抢先治疗

Transplant Proc. 2008 Nov;40(9):3102-3. doi: 10.1016/j.transproceed.2008.08.089.

Chimerism induction and delayed onset of cytomegalovirus (CMV) infection after allogeneic reduced-intensity stem cell transplantation (RIST).异基因减低强度造血干细胞移植（RIST）后嵌合体诱导及巨细胞病毒（CMV）感染延迟发生

Blood. 2002 Oct 1;100(7):2674-5; author reply 2675-6. doi: 10.1182/blood-2002-04-1175.

本文引用的文献

Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation.

Int J Hematol. 2005 Jun;81(5):439-40. doi: 10.1532/ijh97.05036.

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.造血干细胞移植后严重巨细胞病毒血症

Bone Marrow Transplant. 2005 Nov;36(9):813-9. doi: 10.1038/sj.bmt.1705134.

Int J Hematol. 2005 Jan;81(1):69-74. doi: 10.1532/ijh97.a30402.

High variability between results of different in-house tests for cytomegalovirus (CMV) monitoring and a standardized quantitative plasma CMV PCR assay.不同内部巨细胞病毒（CMV）监测检测结果与标准化定量血浆CMV聚合酶链反应检测之间存在高度差异。

J Clin Microbiol. 2002 Jun;40(6):2285-7. doi: 10.1128/JCM.40.6.2285-2287.2002.

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.异基因造血干细胞移植后基于巨细胞病毒（CMV）抗原血症检测指导的CMV疾病抢先治疗：日本单中心经验

Bone Marrow Transplant. 2001 Feb;27(4):437-44. doi: 10.1038/sj.bmt.1702805.

Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.对接受异基因骨髓移植患者的巨细胞病毒疾病采用风险适应性抢先治疗。

Bone Marrow Transplant. 2000 Apr;25(7):765-9. doi: 10.1038/sj.bmt.1702227.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea.

作者信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献